IPO Boutique

Forma Therapeutics Holdings, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...



For IPO Boutique's "scale of 1 to 5" BUY rating on Forma Therapeutics Holdings, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Forma Therapeutics Holdings, Inc.FMTX -
NASDAQ
$16.00-$18.00 $20.00 $40.0013.8 million6/19/2020
Jefferies, SVB Leerink, Credit Suisse
Co-Manager(s):
Health Care
Filing(s):

Filed 2020-05-29
Terms Added 2020-06-15



Forma Therapeutics Holdings, Inc. Quote & Chart - Click for current quote - FMTX

About Forma Therapeutics Holdings, Inc. (adapted from Forma Therapeutics Holdings, Inc. prospectus):
They are a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Our drug discovery expertise has generated a pipeline of small molecule product candidates focused on indications with significant unmet patient need.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "FMTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved